Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria
B Banwell, JL Bennett, R Marignier, HJ Kim… - The Lancet …, 2023 - thelancet.com
Serum antibodies directed against myelin oligodendrocyte glycoprotein (MOG) are found in
patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis …
patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis …
MRI characteristics of neuromyelitis optica spectrum disorder: an international update
Since its initial reports in the 19th century, neuromyelitis optica (NMO) had been thought to
involve only the optic nerves and spinal cord. However, the discovery of highly specific anti …
involve only the optic nerves and spinal cord. However, the discovery of highly specific anti …
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
In patients presenting with a clinically isolated syndrome, MRI can support and substitute
clinical information in the diagnosis of multiple sclerosis by showing disease dissemination …
clinical information in the diagnosis of multiple sclerosis by showing disease dissemination …
International consensus guidance for management of myasthenia gravis: executive summary
Objective: To develop formal consensus-based guidance for the management of myasthenia
gravis (MG). Methods: In October 2013, the Myasthenia Gravis Foundation of America …
gravis (MG). Methods: In October 2013, the Myasthenia Gravis Foundation of America …
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
MP Wattjes, O Ciccarelli, DS Reich, B Banwell… - The Lancet …, 2021 - thelancet.com
Summary The 2015 Magnetic Resonance Imaging in Multiple Sclerosis and 2016
Consortium of Multiple Sclerosis Centres guidelines on the use of MRI in diagnosis and …
Consortium of Multiple Sclerosis Centres guidelines on the use of MRI in diagnosis and …
Myelin-oligodendrocyte glycoprotein antibody-associated disease
R Marignier, Y Hacohen, A Cobo-Calvo… - The Lancet …, 2021 - thelancet.com
Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently
identified autoimmune disorder that presents in both adults and children as CNS …
identified autoimmune disorder that presents in both adults and children as CNS …
[HTML][HTML] MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
Over the past few years, new-generation cell-based assays have demonstrated a robust
association of autoantibodies to full-length human myelin oligodendrocyte glycoprotein …
association of autoantibodies to full-length human myelin oligodendrocyte glycoprotein …
Clinical presentation and prognosis in MOG-antibody disease: a UK study
Abstract See de Seze (doi: 10.1093/brain/awx292) for a scientific commentary on this article.
A condition associated with an autoantibody against MOG has been recently recognized as …
A condition associated with an autoantibody against MOG has been recently recognized as …
[HTML][HTML] Eculizumab in aquaporin-4–positive neuromyelitis optica spectrum disorder
SJ Pittock, A Berthele, K Fujihara, HJ Kim… - … England Journal of …, 2019 - Mass Medical Soc
Background Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing, autoimmune,
inflammatory disorder that typically affects the optic nerves and spinal cord. At least two …
inflammatory disorder that typically affects the optic nerves and spinal cord. At least two …
Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study
Importance Most patients with neuromyelitis optica (NMO) and many with NMO spectrum
disorder have autoantibodies against aquaporin-4 (AQP4-Abs), but recently, myelin …
disorder have autoantibodies against aquaporin-4 (AQP4-Abs), but recently, myelin …